Epoch Investment Partners, Inc. Gilead Sciences, Inc. Transaction History

Epoch Investment Partners, Inc.

$21.7 Billion
Q3 2024

A detailed history of Epoch Investment Partners, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 13,632 shares of GILD stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,632

Previous 15,624 12.75%

Holding current value

$1.23 Million

Previous $1.07 Million 6.63%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $132,647 - $167,308	-1,992 Reduced 12.75%	13,632 $1.14 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $55.1 Million - $63.6 Million	-872,354 Reduced 98.24%	15,624 $1.07 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $10 Million - $12.2 Million	139,907 Added 18.7%	887,978 $65 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $18.1 Million - $20.6 Million	247,652 Added 49.49%	748,071 $60.6 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $3.85 Million - $4.2 Million	-52,093 Reduced 9.43%	500,419 $37.5 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $1.53 Million - $1.75 Million	-20,149 Reduced 3.52%	552,512 $42.6 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $22.7 Million - $25.8 Million	-293,278 Reduced 33.87%	572,661 $47.5 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $2.01 Million - $2.88 Million	-32,217 Reduced 3.59%	865,939 $74.3 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.4 Million - $1.6 Million	-23,476 Reduced 2.55%	898,156 $55.4 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $5.57 Million - $6.27 Million	96,437 Added 11.69%	921,632 $57 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $6.73 Million - $8.43 Million	116,195 Added 16.39%	825,195 $49.1 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $8.04 Million - $9.12 Million	123,883 Added 21.17%	709,000 $51.5 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.02 Million - $1.1 Million	-15,013 Reduced 2.5%	585,117 $40.9 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $38.1 Million - $41.6 Million	600,130 New	600,130 $41.3 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $2.01 Million - $2.45 Million	-27,545 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $7,684 - $9,020	-108 Reduced 0.39%	27,545 $1.97 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.99 Million - $2.36 Million	27,653	27,653 $2.24 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Account

Epoch Investment Partners, Inc. Gilead Sciences, Inc. Transaction History